 Host-Pathogen Interactions
"Host-Pathogen Interactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The interactions between a host and a pathogen, usually resulting in disease.
| Descriptor ID |
D054884
|
| MeSH Number(s) |
G06.590.470 G16.100.380
|
| Concept/Terms |
Host-Pathogen Interactions- Host-Pathogen Interactions
- Host Pathogen Interactions
- Host-Pathogen Interaction
- Interaction, Host-Pathogen
- Interactions, Host-Pathogen
- Pathogen-Host Interactions
- Interaction, Pathogen-Host
- Interactions, Pathogen-Host
- Pathogen Host Interactions
- Pathogen-Host Interaction
- Host-Pathogen Relations
- Host Pathogen Relations
- Host-Pathogen Relation
- Relation, Host-Pathogen
- Relations, Host-Pathogen
|
Below are MeSH descriptors whose meaning is more general than "Host-Pathogen Interactions".
Below are MeSH descriptors whose meaning is more specific than "Host-Pathogen Interactions".
This graph shows the total number of publications written about "Host-Pathogen Interactions" by people in this website by year, and whether "Host-Pathogen Interactions" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 3 | 3 | | 2009 | 4 | 2 | 6 | | 2010 | 3 | 5 | 8 | | 2011 | 6 | 7 | 13 | | 2012 | 7 | 4 | 11 | | 2013 | 10 | 12 | 22 | | 2014 | 13 | 8 | 21 | | 2015 | 8 | 10 | 18 | | 2016 | 5 | 9 | 14 | | 2017 | 7 | 9 | 16 | | 2018 | 8 | 10 | 18 | | 2019 | 5 | 4 | 9 | | 2020 | 8 | 7 | 15 | | 2021 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Host-Pathogen Interactions" by people in Profiles.
-
Guthmiller JJ, Utset HA, Wilson PC. B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat. Viruses. 2021 05 22; 13(6).
-
Dugan HL, Stamper CT, Li L, Changrob S, Asby NW, Halfmann PJ, Zheng NY, Huang M, Shaw DG, Cobb MS, Erickson SA, Guthmiller JJ, Stovicek O, Wang J, Winkler ES, Madariaga ML, Shanmugarajah K, Jansen MO, Amanat F, Stewart I, Utset HA, Huang J, Nelson CA, Dai YN, Hall PD, Jedrzejczak RP, Joachimiak A, Krammer F, Diamond MS, Fremont DH, Kawaoka Y, Wilson PC. Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets. Immunity. 2021 06 08; 54(6):1290-1303.e7.
-
Self WH, Stewart TG, Wheeler AP, El Atrouni W, Bistran-Hall AJ, Casey JD, Cataldo VD, Chappell JD, Cohn CS, Collins JB, Denison MR, de Wit M, Dixon SL, Duggal A, Edwards TL, Fontaine MJ, Ginde AA, Harkins MS, Harrington T, Harris ES, Hoda D, Ipe TS, Jaiswal SJ, Johnson NJ, Jones AE, Laguio-Vila M, Lindsell CJ, Mallada J, Mammen MJ, Metcalf RA, Middleton EA, Mucha S, O'Neal HR, Pannu SR, Pulley JM, Qiao X, Raval JS, Rhoads JP, Schrager H, Shanholtz C, Shapiro NI, Schrantz SJ, Thomsen I, Vermillion KK, Bernard GR, Rice TW. Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults. Trials. 2021 Mar 20; 22(1):221.
-
Sapoval N, Mahmoud M, Jochum MD, Liu Y, Elworth RAL, Wang Q, Albin D, Ogilvie HA, Lee MD, Villapol S, Hernandez KM, Maljkovic Berry I, Foox J, Beheshti A, Ternus K, Aagaard KM, Posada D, Mason CE, Sedlazeck FJ, Treangen TJ. SARS-CoV-2 genomic diversity and the implications for qRT-PCR diagnostics and transmission. Genome Res. 2021 04; 31(4):635-644.
-
Chen HH, Shaw DM, Petty LE, Graff M, Bohlender RJ, Polikowsky HG, Zhong X, Kim D, Buchanan VL, Preuss MH, Shuey MM, Loos RJF, Huff CD, Cox NJ, Bastarache JA, Bastarache L, North KE, Below JE. Host genetic effects in pneumonia. Am J Hum Genet. 2021 01 07; 108(1):194-201.
-
Sakuraba A, Haider H, Sato T. Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality. Viruses. 2020 11 20; 12(11).
-
Zhou Y, Hou Y, Shen J, Mehra R, Kallianpur A, Culver DA, Gack MU, Farha S, Zein J, Comhair S, Fiocchi C, Stappenbeck T, Chan T, Eng C, Jung JU, Jehi L, Erzurum S, Cheng F. A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19. PLoS Biol. 2020 11; 18(11):e3000970.
-
Pinney SP, Giustino G, Halperin JL, Mechanick JI, Neibart E, Olin JW, Rosenson RS, Fuster V. Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes: JACC Focus Seminar. J Am Coll Cardiol. 2020 Oct 27; 76(17):1999-2010.
-
Harris KM, Horn SE, Grant ML, Lang H, Sani G, Jensen-Wachspress MA, Kankate VV, Datar A, Lazarski CA, Bollard CM, Keller MD. T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1. Front Immunol. 2020; 11:575977.
-
Taxy JB, Cibull T. Syphilis: A Contemporary Clinicopathologic Assessment. Am J Surg Pathol. 2020 09; 44(9):1274-1281.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|